With 0.73 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.57 million shares. The 52-week range on SYRE shows that it touched its highest point at $47.97 and its lowest point at $17.56 during that stretch. It currently has a 1-year price target of $58.62. Beta for the stock currently stands at 3.07.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SYRE was down-trending over the past week, with a drop of -11.77%, but this was down by -20.75% over a month. Three-month performance dropped to -34.34% while six-month performance fell -35.09%. The stock lost -33.60% in the past year, while it has lost -21.74% so far this year. A look at the trailing 12-month EPS for SYRE yields -3.16 with Next year EPS estimates of -3.66. For the next quarter, that number is -0.84. This implies an EPS growth rate of -12.04% for this year and -2.64% for next year. EPS is expected to decline by -5.20% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 44.65%.
Float and Shares Shorts:
At present, 60.26 million SYRE shares are outstanding with a float of 51.14 million shares on hand for trading.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SYRE since 3 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 0 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of -$3.96202 being high and -$4.50489 being low. For SYRE, this leads to a yearly average estimate of -$4.24774.
Summary of Insider Activity:
Insiders traded SYRE stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has remained unchanged to 0 while that of sell transactions has remained unmoved to 0 over the past year. The total number of shares bought during that period was 0 while 0 shares were sold.
